Aurobindo Pharma’s Eugia Pharma Receives USFDA Approval for Budesonide Inhalation Suspension

Aurobindo Pharma’s Eugia Pharma Receives USFDA Approval for Budesonide Inhalation Suspension

Aurobindo Pharma’s Eugia Pharma Receives USFDA Approval for Budesonide Inhalation Suspension (0.5 mg/2 mL Single-Dose Ampule) Aurobindo Pharma Limited is delighted to announce that its wholly-owned subsidiary, Eugia Pharma Specialities Limited, has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Budesonide Inhalation Suspension, 0.5 mg/2 mL Single-Dose Ampule….